Digital Respiratory Devices Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Digital Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Digital Respiratory Devices Market is set for substantial growth, projected to increase from USD 44.98 Billion in 2025 to USD 81.09 Billion by 2031, achieving a 10.32% CAGR. This market includes smart inhalers, nebulizers, and spirometers that integrate sensors and connectivity to monitor medication adherence and lung physiology. Key drivers include the rising prevalence of chronic respiratory conditions and the growing demand for remote patient monitoring, which facilitates timely medical interventions. In 2025, chronic respiratory diseases affected 81.7 million people in the WHO European Region, highlighting the critical need for advanced management tools. However, significant challenges like the high cost of developing and acquiring these connected technologies, coupled with limited reimbursement frameworks, could hinder market expansion, making these devices unaffordable for many and restricting their adoption in regions with limited healthcare funding. This financial barrier remains a major obstacle to widespread global implementation.
Market Driver
The increasing global incidence of asthma and COPD is a primary driver for the Digital Respiratory Devices Market, creating a strong demand for advanced disease management tools like smart inhalers to prevent exacerbations. This demand is further amplified by worsening environmental conditions; for instance, 131 million people in the U.S. live with unhealthy air pollution levels, increasing respiratory risks. Concurrently, the rise of remote patient monitoring (RPM) and telehealth solutions is transforming care delivery by enabling real-time data transmission via IoT connectivity, allowing personalized treatment adjustments without frequent hospital visits. This shift facilitates proactive interventions, improving patient adherence and clinical outcomes. The widespread adoption of connected devices, with over 26 million deployed globally by ResMed, underscores the established infrastructure for value-based care, making digital respiratory devices integral to modern medicine.
Market Challenge
A major impediment to market expansion is the substantial capital required for the development and procurement of connected respiratory technologies. Manufacturers face high research and engineering costs, which translate into elevated retail prices for smart inhalers and monitoring devices. Furthermore, the lack of comprehensive reimbursement policies in many regions forces patients to pay out-of-pocket, making these advanced solutions difficult for healthcare systems, especially in economically constrained areas, to justify over less expensive traditional alternatives. This economic barrier directly limits the uptake and market penetration of digital solutions, exacerbating the already high financial strain on patients with respiratory conditions. For example, asthma patients incurred annual medical expenses $3,266 higher than individuals without the condition in 2025, making the additional cost of unsubsidized digital devices prohibitive and stalling global market growth.
Market Trends
Strategic collaborations between pharmaceutical companies and medical technology firms are fundamentally reshaping the market by moving towards co-development models that bundle medication with digital connectivity. These partnerships allow pharmaceutical companies to utilize sensor technologies for enhanced adherence tracking, while device manufacturers gain access to broader patient networks and distribution channels. This synergistic approach validates the commercial viability of connected ecosystems, as evidenced by companies like Adherium, which surpassed its 2025 shipment milestones by delivering 4,666 connected devices, confirming rising demand for integrated monitoring solutions. Simultaneously, the development of eco-friendly and sustainable device designs is gaining significant momentum. This trend is driven by increasing regulatory pressure to decarbonize respiratory care, leading to the engineering of inhalers with low-global-warming-potential propellants and reusable components. Corporations are actively investing in green innovation to align with global ESG mandates, with Chiesi Farmaceutici, for example, developing a Carbon Minimal Inhaler designed to reduce propellant gas emissions by up to 90% compared to traditional devices.
Key Market Players
* COHERO Health Inc.
* Cognita Labs llc
* Adherium Limited
* Amiko Digital Health Limited
* Teva Pharmaceuticals Industries Ltd.
* Propeller Health
* Novartis AG
* Pneuma Respiratory Inc.
* 3M Health Care Limited
* AireHealth, Inc.
Report Scope
In this report, the Global Digital Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Digital Respiratory Devices Market, By Product
* Smart Inhalers & Nebulizers
* Sensors & Apps
* Others
# Digital Respiratory Devices Market, By Indication
* Asthma
* COPD
* Others
# Digital Respiratory Devices Market, By Distribution Channel
* Hospital Pharmacies
* Retail Pharmacies
* Online Pharmacies
# Digital Respiratory Devices Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Digital Respiratory Devices Market.
Available Customizations:
Global Digital Respiratory Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Digital Respiratory Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others)
5.2.2. By Indication (Asthma, COPD, Others)
5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Digital Respiratory Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Indication
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Digital Respiratory Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Indication
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Digital Respiratory Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Indication
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Digital Respiratory Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Indication
6.3.3.2.3. By Distribution Channel
7. Europe Digital Respiratory Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Indication
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Digital Respiratory Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Indication
7.3.1.2.3. By Distribution Channel
7.3.2. France Digital Respiratory Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Indication
7.3.2.2.3. By Distribution Channel
7.3.3. United Kingdom Digital Respiratory Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Indication
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Digital Respiratory Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Indication
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Digital Respiratory Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Indication
7.3.5.2.3. By Distribution Channel
8. Asia Pacific Digital Respiratory Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Indication
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Digital Respiratory Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Indication
8.3.1.2.3. By Distribution Channel
8.3.2. India Digital Respiratory Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Indication
8.3.2.2.3. By Distribution Channel
8.3.3. Japan Digital Respiratory Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Indication
8.3.3.2.3. By Distribution Channel
8.3.4. South Korea Digital Respiratory Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Indication
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Digital Respiratory Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Indication
8.3.5.2.3. By Distribution Channel
9. Middle East & Africa Digital Respiratory Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Indication
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Digital Respiratory Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Indication
9.3.1.2.3. By Distribution Channel
9.3.2. UAE Digital Respiratory Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Indication
9.3.2.2.3. By Distribution Channel
9.3.3. South Africa Digital Respiratory Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Indication
9.3.3.2.3. By Distribution Channel
10. South America Digital Respiratory Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Indication
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Digital Respiratory Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Indication
10.3.1.2.3. By Distribution Channel
10.3.2. Colombia Digital Respiratory Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Indication
10.3.2.2.3. By Distribution Channel
10.3.3. Argentina Digital Respiratory Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Indication
10.3.3.2.3. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Digital Respiratory Devices Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. COHERO Health Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Cognita Labs llc
15.3. Adherium Limited
15.4. Amiko Digital Health Limited
15.5. Teva Pharmaceuticals Industries Ltd.
15.6. Propeller Health
15.7. Novartis AG
15.8. Pneuma Respiratory Inc.
15.9. 3M Health Care Limited
15.10. AireHealth, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們